World Antibiotic Awareness Week primarily aims to increase awareness around the global health threat of antimicrobial resistance, which could be responsible for over 10 million deaths by 2050 if urgent action is not taken. However, the week also serves to encourage best practices among healthcare workers, the general public and policy makers to try and avoid a further exacerbation of antimicrobial resistance.
In light of this important week, we are hosting a panel discussion with experts in the field answering questions on stewardship, upcoming research that could make a difference, and what the future might hold in terms of policy and fields outside of human health. We hope that this forum will provide an opportunity for valuable discussion on some of the key topics in the current debate around antimicrobial resistance – from bench to bedside – and also allow you, the audience, a chance to pose questions to our panelists.
What will you learn?
- The roles of communication, leadership, and training in antimicrobial stewardship
- An update on diagnostics, surveillance and new strategies to prevent antimicrobial-resistant infections
- The action needed outside of the healthcare sector, including agriculture and a ‘One Health’ approach
- The challenges and solutions associated with antimicrobial drug development and alternative treatment strategies
- Future research and policy initiatives – what should we be doing?
Who may this interest?
Healthcare professionals, researchers, academics, students and professionals working in – or interested in – the field of antimicrobial resistance.
Clinical Professor, Texas A&M College of Medicine, TX, USA
Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston (TX, USA) in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases. He was VP Research and Infectious Diseases HCA Healthcare until 2018. He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and was on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. He was the first recipient of the IDSA Annual Clinician Award.
In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services. He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013 and 2014. He is on the US FDA Anti-Infective Drug Advisory Group and is co-chair of the NQF Patient Safety Steering Committee. He holds a faculty position as Clinical Professor at Texas A&M College of Medicine (TX, USA), Senior Lecturer Department of Population Medicine Harvard Medical School (MA, USA), and Professor Distinguished Senior Fellow, School of Public Health, George Mason University (VA, USA). He has published over 100 articles and chapters.
Elizabeth Dodds Ashley
Associate Professor of Medicine, Division of Infectious Diseases and International Health, Duke University, NC, USA
Dr. Dodds Ashley is an associate professor of medicine with the Division of Infectious Diseases and International Health at Duke University (NC, USA). She also serves as the director of operations and liaison pharmacist with the Duke Antimicrobial Stewardship Outreach Network (DASON) based at Duke University. She received her Doctor of Pharmacy degree from the Bouvé College of Pharmacy and Health Sciences at Northeastern University, Boston (MA, USA). She completed her pharmacy practice residency at Duke University Health System and a specialty residency in adult internal medicine/infectious disease with Duke University Health System and Campbell University (NC, USA) before joining the Department of Medicine at Duke University Medical Center. In 2006 she completed her Masters in Health Science in clinical research at Duke University School of Medicine.
Her teaching, research, and patient care activities focus on appropriate use of anti-infective agents, antimicrobial stewardship, and infectious diseases in the transplant population. She has served as a member of the Antimicrobial Resistance Working Group at the Centers for Disease Control and Prevention (GA, USA), and an expert panel member of the Transatlantic Taskforce for Antimicrobial Resistance, among other appointments. She was the recipient of an Society of Infectious Diseases Pharmacists (SIDP) Research Award (2006–2007) and has served the society as a member of the Strategic Planning Committee (2007–2008) and the Board of Directors (2010–2012). She was also chair of the Infectious Diseases PRN of the American College of Clinical Pharmacy, and a former SIDP board member. She was the 2018 president of SIDP.
BBSRC David Phillips Fellow, Institute of Microbiology and Infection, University of Birmingham, UK
Dr. Jessica Blair graduated from the University of Oxford (UK) in 2006 with a degree in Biological Sciences and with a PhD from Birmingham (UK) in 2010. Subsequently, Jess stayed in Birmingham where her post-doctoral research covered various aspects of antibiotic resistance. Dr Blair was awarded a BBSRC David Phillip’s Fellowship in 2015 and now runs her own research group in the Institute of Microbiology and Infection studying the molecular mechanisms of antibiotic resistance.
Post-doctoral Research Fellow, Health Services Research Unit, University of Aberdeen, UK
Magdalena is a Post-doctoral Research Fellow at the Health Services Research Unit (HSRU) and collaborator of the Aberdeen Centre for Health Data Science (ACHDS), University of Aberdeen (UK). Her research focuses primarily on improving healthcare provision in the UK and Brazil, particularly for patients with complex healthcare needs that require a multidisciplinary team approach (such as antimicrobial stewardship or integrated care). She has a particular interest and growing expertise in sustainable healthcare improvement through data-driven innovation, such as the use of AI-enabled healthcare technologies. She is a passionate promoter and advanced user of implementation science methods, in which a behavioral approach plays an indispensable role.
Scott A. McEwen
Professor, Department of Population Medicine, Ontario Veterinary College, University of Guelph, Canada
Scott McEwen obtained his DVM and Doctor of Veterinary Science degrees from the University of Guelph (Ontario, Canada). He is currently a Professor in the Department of Population Medicine, Ontario Veterinary College. His research focuses on the epidemiology of foodborne infections in animals and humans, including antimicrobial resistance. Since 1986 he has supervised over 60 MSc and PhD students. He is author or co-author of over 250 publications in refereed scientific journals and several book chapters.
He consulted on technical matters with several organizations at the provincial, national and international levels, notably the Public Health Agency of Canada, Health Canada, the US FDA, the Centers for Disease Control and the WHO. He chaired Health Canada’s Advisory Committee on Animal Uses of Antimicrobials and Impact on Resistance and Human Health 1999–2002. He also chaired the WHO’s evaluation of the termination of the use of antimicrobial growth promoters in Denmark, the FAO/OIE/WHO Expert Workshop on Non-human Antimicrobial Usage and Antimicrobial Resistance: Scientific Assessment and the Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials. He participated on the Guideline Development Committee of the WHO guidelines on use of medically important antimicrobials in food-producing animals.